Home » Stocks » MD

MEDNAX, Inc. (MD)

Stock Price: $31.59 USD 0.01 (0.03%)
Updated Jun 24, 2021 2:07 PM EDT - Market open
Market Cap 2.74B
Revenue (ttm) 1.83B
Net Income (ttm) -760.13M
Shares Out 86.28M
EPS (ttm) -9.07
PE Ratio n/a
Forward PE 26.46
Dividend n/a
Dividend Yield n/a
Trading Day June 24
Last Price $31.59
Previous Close $31.58
Change ($) 0.01
Change (%) 0.03%
Day's Open 31.58
Day's Range 31.16 - 31.89
Day's Volume 117,562
52-Week Range 12.47 - 34.19

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

MEDNAX's (MD) Q1 results reflect lower costs. However, the same is partly offset by softer revenues.

1 month ago - Zacks Investment Research

Investors are cheering the company's Q1 results.

1 month ago - The Motley Fool

Mednax (MD) delivered earnings and revenue surprises of 60.00% and 2.36%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax, Inc. (NYSE: MD), the national medical group specializing in prenatal, neonatal, and pediatric services, today reported earnings from continuing op...

1 month ago - Business Wire

Varied companies across the vast healthcare space might have been affected differently by the COVID crisis during the first quarter.

Other stocks mentioned: ELAN, MODV
1 month ago - Zacks Investment Research

Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax 2021 First Quarter Conference Call/Webcast Scheduled for Friday, May 7, 2021

2 months ago - Business Wire

RESTON, Va., April 21, 2021 /PRNewswire/ -- Oteemo, Inc., a leader in DevSecOps transformation and cloud native application development, today announced its successful transformation effort with Mednax,...

2 months ago - PRNewsWire

Riding high on strategic initiatives and telehealth medicine, MEDNAX (MD) holds potential to reap benefits for investors.

3 months ago - Zacks Investment Research

Mednax (MD) reported earnings 30 days ago. What's next for the stock?

3 months ago - Zacks Investment Research

Mednax (MD) collaborates with NighLight with an aim to offer enhanced pediatric care in Texas.

3 months ago - Zacks Investment Research

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- #healthcare--Mednax, Inc. (NYSE: MD), specializing in prenatal, neonatal and pediatric services, announced its affiliation with NightLight Pediatric Urgent Care

3 months ago - Business Wire

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax to Present at Upcoming Investor Conferences

4 months ago - Business Wire

MEDNAX's (MD) fourth-quarter results reflect muted revenues caused by the COVID-19 pandemic.

4 months ago - Zacks Investment Research

The company released its earnings report for the fourth quarter.

4 months ago - The Motley Fool

Mednax (MD) delivered earnings and revenue surprises of -19.35% and -8.64%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Shares of Mednax (NYSE:MD) fell 0.2% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 72.53% year over year to $0.25, which missed the estimate...

4 months ago - Benzinga

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax Reports Fourth Quarter Results

4 months ago - Business Wire

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax 2020 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 18, 2021

4 months ago - Business Wire

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- #neoconference2021--The virtual NEO conference will continue its longstanding tradition of addressing key areas of neonatal management to improve newborn outcomes.

4 months ago - Business Wire

OKLAHOMA CITY--(BUSINESS WIRE)-- #FedermanSherwood--Federman & Sherwood Files First Data Breach Case Against MedNax, Inc. and Pediatrix Medical Group, a MedNax Company

5 months ago - Business Wire

Riding high on its strategic efforts and cost-cutting measures, MEDNAX (MD) holds enough potential to reap benefits for investors.

5 months ago - Zacks Investment Research

EL SEGUNDO, Calif.--(BUSINESS WIRE)-- #PracticeNotCompany--Radiology Partners (RP), the leading radiology practice in the U.S., today announced the completion of its acquisition of MEDNAX Radiology Solu...

6 months ago - Business Wire

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--MEDNAX Completes Sale of MEDNAX Radiology Solutions to Radiology Partners

6 months ago - Business Wire

Mednax (MD) reported earnings 30 days ago. What's next for the stock?

6 months ago - Zacks Investment Research

MEDNAX's (MD) third-quarter results reflect muted revenues and high costs, partly offset by lower interest expense.

7 months ago - Zacks Investment Research

MEDNAX, Inc. (MD) CEO Mark Ordan on Q3 2020 Results - Earnings Call Transcript

7 months ago - Seeking Alpha

Shares of Mednax (NYSE:MD) rose 5.3% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share fell 59.34% year over year to $0.37, which missed the estimate of $...

7 months ago - Benzinga

Mednax (MD) delivered earnings and revenue surprises of -7.50% and -13.87%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

7 months ago - Zacks Investment Research

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--MEDNAX Reports Third Quarter Results

7 months ago - Business Wire

Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

7 months ago - Zacks Investment Research

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX 2020 Third Quarter Conference Call/Webcast Scheduled for Friday, November 6, 2020

8 months ago - Business Wire

Why this health care strategist likes the work-from-home trade

YouTube video

CNBC's Kelly Evans discusses the best work-from-home health care equity investments with Jared Holz of Jefferies Health Care Strategy.

Other stocks mentioned: ABBV, ABT
9 months ago - CNBC Television

Riding on restructuring as well as cost-cutting initiatives, MEDNAX (MD) holds potential to reap benefits for investors.

9 months ago - Zacks Investment Research

NEW YORK, Sept. 15, 2020 /PRNewswire/ -- DLA Piper represented MEDNAX, Inc.

9 months ago - PRNewsWire

MEDNAX (MD) reaches an agreement with Radiology Partners to sell its MEDNAX Radiology Solutions, which will lower its debt load and restructure its business.

9 months ago - Zacks Investment Research

MEDNAX (MD) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

9 months ago - Zacks Investment Research

Mednax Inc. MD, +0.73% said Thursday it has reached an agreement to sell its radiology business to physician-owned Radiology Partners for $885 million in cash.

9 months ago - Market Watch

EL SEGUNDO, Calif.--(BUSINESS WIRE)--Radiology Partners (RP), the leading radiology practice in the U.S.

9 months ago - Business Wire

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX Announces Agreement to Sell MEDNAX Radiology Solutions to Radiology Partners

9 months ago - Business Wire

Mednax (MD) reported earnings 30 days ago. What's next for the stock?

9 months ago - Zacks Investment Research

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX Announces Financial Leadership Transition - C.

9 months ago - Business Wire

MEDNAX, Inc. (MD) CEO Mark Ordan on Q2 2020 Results - Earnings Call Transcript

10 months ago - Seeking Alpha

MEDNAX's (MD) Q2 results reflect lower expenses, offset by soft revenues.

10 months ago - Zacks Investment Research

Shares of Mednax (NYSE:MD) were flat in pre-market trading after the company reported Q2 results.

10 months ago - Benzinga

Mednax (MD) delivered earnings and revenue surprises of 113.33% and -13.83%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

10 months ago - Zacks Investment Research

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX Reports Second Quarter Results Results from Continuing Operations Reflect Significant Recovery in Second Half of Quarter Following Initial Disr

10 months ago - Business Wire

Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

11 months ago - Zacks Investment Research

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX 2020 Second Quarter Conference Call/Webcast Scheduled for Thursday, July 30, 2020

11 months ago - Business Wire

Pressure from the COVID-19 impact on global economy and lack of solvency make MEDNAX (MD) an unattractive bet.

11 months ago - Zacks Investment Research

About MD

MEDNAX, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectan... [Read more...]

Industry
Medical Care Facilities
IPO Date
Sep 19, 1995
Stock Exchange
NYSE
Ticker Symbol
MD
Full Company Profile

Financial Performance

In 2020, MEDNAX, Inc.'s revenue was $1.73 billion, a decrease of -2.57% compared to the previous year's $1.78 billion. Losses were -$796.49 million, -46.82% less than in 2019.

Financial Statements

Analyst Forecasts

According to 11 analysts, the average rating for MEDNAX, Inc. stock is "Hold." The 12-month stock price forecast is 27.30, which is a decrease of -13.58% from the latest price.

Price Target
$27.30
(-13.58% downside)
Analyst Consensus: Hold